Table 1 Basic patient characteristics in women with HPV-associated and non-HPV-associated malignancies
From: What do women with gynecologic cancer know about HPV and their individual disease? A pilot study
Cervical cancer (n = 30) | Vaginal & vulvar cancer (n = 21) | Ovarian cancer (n = 30) | Endometrial cancer (n = 30) | P | |
|---|---|---|---|---|---|
Age at the survey (years)* | 51.87 ± 9.97 | 63.52 ± 14.46 | 60.70 ± 10.06 | 68.37 ± 9.34 | 0.001 |
Years since diagnosis* | 3.55 ± 3.19 | 4.73 ± 3.99 | 4.58 ± 4.07 | 2.95 ± 2.2 | 0.361 |
Pre-therapeutic BMI (kg/m2)* | 29.20 ± 9.06 | 28.984 ± 8.41 | 27.49 ± 4.95 | 28.48 ± 5.89 | 0.576 |
Post-therapeutic BMI (kg/m2)* | 27.54 ± 7.29 | 28.12 ± 6.59 | 27.16 ± 5.74 | 28.60 ± 5.49 | 0.577 |
Correctly named diagnosis# | 22 (73,3) | 9 (42,9) | 24 (80) | 21 (70) | 0.008 |
Educational level | |||||
No school graduation# | 1 (3.3) | 1 (4.8) | 0 | 1 (3.3) | 0.86 |
Secondary school graduation# | 18 (60) | 16 (76.2) | 18 (60) | 21 (70) | |
High school graduation# | 4 (13.3) | 2 (9.5) | 3 (10) | 4 (13.3) | |
Academic degree# | 7 (23.3) | 2 (9.5) | 9 (30) | 4 (13.3) |